A network pharmacology approach to investigate the pharmacological effects of Guizhi Fuling Wan on uterine fibroids
- Authors:
- Liuting Zeng
- Kailin Yang
- Huiping Liu
- Guomin Zhang
-
Affiliations: The Basic Medical Laboratory of Hunan University of Chinese Medicine, Changsha, Hunan 410208, P.R. China - Published online on: September 21, 2017 https://doi.org/10.3892/etm.2017.5170
- Pages: 4697-4710
-
Copyright: © Zeng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
 |
 |
|
Townsend DE, Sparkes RS, Baluda MC and McClelland G: Unicellular histogenesis of uterine leiomyomas as determined by electrophoresis by glucose-6-phosphate dehydrogenase. Am J Obstet Gynecol. 107:1168–1173. 1970. View Article : Google Scholar : PubMed/NCBI | |
|
Pandis N, Heim S, Bardi G, Flodérus UM, Willén H, Mandahl N and Mitelman F: Chromosome analysis of 96 uterine leiomyomas. Cancer Genet Cytogenet. 55:11–18. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Rein MS: Advances in uterine leiomyoma research: The progesterone hypothesis. Environ Health Perspect. 108 Suppl 5:S791–S793. 2000. View Article : Google Scholar | |
|
Borahay MA, Al-Hendy A, Kilic GS and Boehning D: Signaling pathways in leiomyoma: Understanding pathobiology and implications for therapy. Mol Med. 21:242–256. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Levy BS: Modern management of uterine fibroids. Acta Obstet Gynecol Scand. 87:812–823. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Maruo T, Ohara N, Wang J and Matsuo H: Sex steroidal regulation of uterine leiomyoma growth and apoptosis. Hum Reprod Update. 10:207–220. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Grigorieva V, Chen-Mok M, Tarasova M and Mikhailov A: Use of a levonorgestrel-releasing intrauterine system to treat bleeding related to uterine leiomyomas. Fertil Steril. 79:1194–1198. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Falcone T and Bedaiwy MA: Minimally invasive management of uterine fibroids. Curr Opin Obstet Gynecol. 14:401–407. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Lethaby A, Vollenhoven B and Sowter M: Pre-operative GnRH analogue therapy before hysterectomy or myomectomy for uterine fibroids. Cochrane Database Syst Rev: CD000547. 2001. View Article : Google Scholar | |
|
Tristan M, Orozco LJ, Steed A, Ramírez-Morera A and Stone P: Mifepristone for uterine fibroids. Cochrane Database Syst Rev. doi: 10.1002/14651858.CD007687.pub2. | |
|
Lumsden MA: Modern management of fibroids. Obstet Gynaecol Reprod Med. 20:82–86. 2010. View Article : Google Scholar | |
|
Walker CL and Stewart EA: Uterine fibroids: The elephant in the room. Science. 308:1589–1592. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Lethaby A, Vollenhoven B and Sowter M: Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: A systematic review. BJOG. 109:1097–1108. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Sankaran S and Manyonda IT: Medical management of fibroids. Best Pract Res Clin Obstet Gynaecol. 22:655–676. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Yan J, Li CP and Liu SS: Study of disease names treated by Guizhi Fuling pills based on data mining technology. Chin J Mod Drug Appl. 6:85–86. 2012.(In Chinese). | |
|
Fan YS: Jin Gui Yao Lue. China Press of Traditional Chinese Medicine; Beijing: 2007 | |
|
National Commission of Chinese Pharmacopoeia, . Pharmacopoeia of the People's Republic of China. Beijing China Med Scie Technol Press; 1. pp. 9842010, (In Chinese). | |
|
Chen NN, Han M, Yang H, Yang GY, Wang YY, Wu XK and Liu JP: Chinese herbal medicine Guizhi Fuling Formula for treatment of uterine fibroids: A systematic review of randomised clinical trials. BMC Complement Altern Med. 14:22014. View Article : Google Scholar : PubMed/NCBI | |
|
Liu AL and Du GH: Network pharmacology: New guidelines for drug discovery. Yao Xue Xue Bao. 45:1472–1477. 2010.(In Chinese). PubMed/NCBI | |
|
Liang X, Li H and Li S: A novel network pharmacology approach to analyse traditional herbal formulae: The Liu-Wei-Di-Huang pill as a case study. Mol Biosyst. 10:1014–1022. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Li S, Zhang B, Jiang D, Wei Y and Zhang N: Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae. BMC Bioinformatics. 11 Suppl 11:S62010. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng CS, Xu XJ, Ye HZ, Wu GW, Li XH, Xu HF and Liu XX: Network pharmacology-based prediction of the multi-target capabilities of the compounds in Taohong Siwu decoction, and their application in osteoarthritis. Exp Ther Med. 6:125–132. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Chen FP, Chang CM, Hwang SJ, Chen YC and Chen FJ: Chinese herbal prescriptions for osteoarthritis in Taiwan: Analysis of National Health Insurance dataset. BMC Complement Altern Med. 14:912014. View Article : Google Scholar : PubMed/NCBI | |
|
Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, et al: TCMSP: A database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 6:132014. View Article : Google Scholar : PubMed/NCBI | |
|
Chen L, Wang D, Wu J, Yu B and Zhu D: Identification of multiple constituents in the traditional Chinese medicine formula GuiZhiFuLing-Wan by HPLC-DAD-MS/MS. J Pharm Biomed Anal. 49:267–275. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Liu X, Ouyang S, Yu B, Liu Y, Huang K, Gong J, Zheng S, Li Z, Li H and Jiang H: PharmMapper server: A web server for potential drug target identification using pharmacophore mapping approach. Nucleic Acids Res. 38:(Web Server Issue). W609–W614. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Hamosh A, Scott AF, Amberger JS, Bocchini CA and McKusick VA: Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res. 33(Database Issue): D514–D517. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, et al: STRING v10: Protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 43(Database Issue): D447–D452. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Orchard S, Ammari M, Aranda B, Breuza L, Briganti L, Broackes-Carter F, Campbell NH, Chavali G, Chen C, del-Toro N, et al: The MIntAct project-IntAct as a common curation platform for 11 molecular interaction databases. Nucleic Acids Res. 42(Database Issue): D358–D363. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Franz M, Lopes CT, Huck G, Dong Y, Sumer O and Bader GD: Cytoscape.js: A graph theory library for visualisation and analysis. Bioinformatics. 32:309–311. 2016.PubMed/NCBI | |
|
Missiuro PV, Liu K, Zou L, Ross BC, Zhao G, Liu JS and Ge H: Information flow analysis of interactome networks. PLoS Comput Biol. 5:e10003502009. View Article : Google Scholar : PubMed/NCBI | |
|
Raman K, Damaraju N and Joshi GK: The organisational structure of protein networks: Revisiting the centrality-lethality hypothesis. Syst Synth Biol. 8:73–81. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang Y, Bai M, Zhang B, Liu C, Guo Q, Sun Y, Wang D, Wang C, Jiang Y, Lin N and Li S: Uncovering pharmacological mechanisms of Wu-tou decoction acting on rheumatoid arthritis through systems approaches: Drug-target prediction, network analysis and experimental validation. Sci Rep. 5:94632015. View Article : Google Scholar : PubMed/NCBI | |
|
Huang da W, Sherman BT and Lempicki RA: Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 4:44–57. 2009.PubMed/NCBI | |
|
Farber M, Conrad S, Heinrichs WL and Herrmann WL: Estradiol binding by fibroid tumors and normal myometrium. Obstet Gynecol. 40:479–486. 1972.PubMed/NCBI | |
|
Puukka MJ, Kontula KK, Kauppila AJ, Janne OA and Vihko RK: Estrogen receptor in human myoma tissue. Mol Cell Endocrinol. 6:35–44. 1976. View Article : Google Scholar : PubMed/NCBI | |
|
Kim JJ, Sefton EC and Bulun SE: Progesterone receptor action in leiomyoma and endometrial cancer. Prog Mol Biol Transl Sci. 87:53–85. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Kim JJ, Kurita T and Bulun SE: Progesterone action in endometrial cancer, endometriosis, uterine fibroids, and breast cancer. Endocr Rev. 34:130–162. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Islam MS, Protic O, Stortoni P, Grechi G, Lamanna P, Petraglia F, Castellucci M and Ciarmela P: Complex networks of multiple factors in the pathogenesis of uterine leiomyoma. Fertil Steril. 100:178–193. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Ciarmela P, Islam MS, Reis FM, Gray PC, Bloise E, Petraglia F, Vale W and Castellucci M: Growth factors and myometrium: Biological effects in uterine fibroid and possible clinical implications. Hum Reprod Update. 17:772–790. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Marsh EE and Bulun SE: Steroid hormones and leiomyomas. Obstet Gynecol Clin North Am. 33:59–67. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Sozen I and Arici A: Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata. Fertil Steril. 78:1–12. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Nierth-Simpson EN, Martin MM, Chiang TC, Melnik LI, Rhodes LV, Muir SE, Burow ME and McLachlan JA: Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: Implications for proliferation. Endocrinology. 150:2436–2445. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Benassayag C, Leroy MJ, Rigourd V, Robert B, Honoré JC, Mignot TM, Vacher-Lavenu MC, Chapron C and Ferré F: Estrogen receptors (ERalpha/ERbeta) in normal and pathological growth of the human myometrium: Pregnancy and leiomyoma. Am J Physiol. 276:E1112–E1118. 1999.PubMed/NCBI | |
|
Kovács KA, Oszter A, Göcze PM, Környei JL and Szabó I: Comparative analysis of cyclin D1 and oestrogen receptor (alpha and beta) levels in human leiomyoma and adjacent myometrium. Mol Hum Reprod. 7:1085–1091. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Maekawa R, Sato S, Yamagata Y, Asada H, Tamura I, Lee L, Okada M, Tamura H, Takaki E, Nakai A and Sugino N: Genome-wide DNA methylation analysis reveals a potential mechanism for the pathogenesis and development of uterine leiomyomas. PLoS One. 8:e666322013. View Article : Google Scholar : PubMed/NCBI | |
|
Ishikawa H, Ishi K, Serna VA, Kakazu R, Bulun SE and Kurita T: Progesterone is essential for maintenance and growth of uterine leiomyoma. Endocrinology. 151:2433–2442. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Lange CA: Integration of progesterone receptor action with rapid signaling events in breast cancer models. J Steroid Biochem Mol Biol. 108:203–212. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Boonyaratanakornkit V, Scott MP, Ribon V, Sherman L, Anderson SM, Maller JL, Miller WT and Edwards DP: Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. Mol Cell. 8:269–280. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Maruo T, Matsuo H, Samoto T, Shimomura Y, Kurachi O, Gao Z, Wang Y, Spitz IM and Johansson E: Effects of progesterone on uterine leiomyoma growth and apoptosis. Steroids. 65:585–592. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Shimomura Y, Matsuo H, Samoto T and Maruo T: Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma. J Clin Endocrinol Metab. 83:2192–2198. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Burroughs KD, Howe SR, Okubo Y, Fuchs-Young R, LeRoith D and Walker CL: Dysregulation of IGF-I signaling in uterine leiomyoma. J Endocrinol. 172:83–93. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Peng L, Wen Y, Han Y, Wei A, Shi G, Mizuguchi M, Lee P, Hernando E, Mittal K and Wei JJ: Expression of insulin-like growth factors (IGFs) and IGF signaling: Molecular complexity in uterine leiomyomas. Fertil Steril. 91:2664–2675. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Chang CC, Hsieh YY, Lin WH and Lin CS: Leiomyoma and vascular endothelial growth factor gene polymorphisms: A systematic review. Taiwan J Obstet Gynecol. 49:247–253. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Rossi MJ, Chegini N and Masterson BJ: Presence of epidermal growth factor, platelet-derived growth factor, and their receptors in human myometrial tissue and smooth muscle cells: Their action in smooth muscle cells in vitro. Endocrinology. 130:1716–1727. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Helmke BM, Markowski DN, Müller MH, Sommer A, Müller J, Möller C and Bullerdiek J: HMGA proteins regulate the expression of FGF2 in uterine fibroids. Mol Hum Reprod. 17:135–142. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Kolch W: Meaningful relationships: The regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. Biochem J. 351:289–305. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Crabtree JS, Jelinsky SA, Harris HA, Choe SE, Cotreau MM, Kimberland ML, Wilson E, Saraf KA, Liu W, McCampbell AS, et al: Comparison of human and rat uterine leiomyomata: Identification of a dysregulated mammalian target of rapamycin pathway. Cancer Res. 69:6171–6178. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Swartz CD, Afshari CA, Yu L, Hall KE and Dixon D: Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines. Mol Hum Reprod. 11:441–450. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Yu L, Saile K, Swartz CD, He H, Zheng X, Kissling GE, Di X, Lucas S, Robboy SJ and Dixon D: Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas. Mol Med. 14:264–275. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Karra L, Shushan A, Ben-Meir A, Rojansky N, Klein BY, Shveiky D, Levitzki R and Ben-Bassat H: Changes related to phosphatidylinositol 3-kinase/Akt signaling in leiomyomas: Possible involvement of glycogen synthase kinase 3alpha and cyclin D2 in the pathophysiology. Fertil Steril. 93:2646–2651. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Jeong YJ, Noh EM, Lee YR, Yu HN, Jang KY, Lee SJ, Kim J and Kim JS: 17β-estradiol induces up-regulation of PTEN and PPARγ in leiomyoma cells, but not in normal cells. Int J Oncol. 36:921–927. 2010.PubMed/NCBI | |
|
Chegini N, Luo X, Ding L and Ripley D: The expression of Smads and transforming growth factor beta receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. Mol Cell Endocrinol. 209:9–16. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Fayed YM, Tsibris JC, Langenberg PW and Robertson AL Jr: Human uterine leiomyoma cells: Binding and growth responses to epidermal growth factor, platelet-derived growth factor, and insulin. Lab Invest. 60:30–37. 1989.PubMed/NCBI | |
|
Ren Y, Yin H, Tian R, Cui L, Zhu Y, Lin W, Tang XD, Gui Y and Zheng XL: Different effects of epidermal growth factor on smooth muscle cells derived from human myometrium and from leiomyoma. Fertil Steril. 96:1015–1020. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Brown LF, Detmar M, Tognazzi K, Abu-Jawdeh G and Iruela-Arispe ML: Uterine smooth muscle cells express functional receptors (flt-1 and KDR) for vascular permeability factor/vascular endothelial growth factor. Lab Invest. 76:245–255. 1997.PubMed/NCBI | |
|
Sanci M, Dikis C, Inan S, Turkoz E, Dicle N and Ispahi C: Immunolocalization of VEGF VEGF receptors, EGF-R and Ki-67 in leiomyoma, cellular leiomyoma and leiomyosarcoma. Acta Histochem. 113:317–325. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Gentry CC, Okolo SO, Fong LF, Crow JC, Maclean AB and Perrett CW: Quantification of vascular endothelial growth factor-A in leiomyomas and adjacent myometrium. Clin Sci (Lond). 101:691–695. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Ono M, Yin P, Navarro A, Moravek MB, JS V Coon, Druschitz SA, Serna VA, Qiang W, Brooks DC, Malpani SS, et al: Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth. Proc Natl Acad Sci USA. 110:pp. 17053–17058. 2013; View Article : Google Scholar : PubMed/NCBI | |
|
Catherino WH and Malik M: Uterine leiomyomas express a molecular pattern that lowers retinoic acid exposure. Fertil Steril. 87:1388–1398. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Olive DL, Lindheim SR and Pritts EA: Non-surgical management of leiomyoma: Impact on fertility. Curr Opin Obstet Gynecol. 16:239–243. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Fiscella K, Eisinger SH, Meldrum S, Feng C, Fisher SG and Guzick DS: Effect of mifepristone for symptomatic leiomyomata on quality of life and uterine size: A randomized controlled trial. Obstet Gynecol. 108:1381–1387. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Donnez J, Tatarchuk TF, Bouchard P, Puscasiu L, Zakharenko NF, Ivanova T, Ugocsai G, Mara M, Jilla MP, Bestel E, et al: Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med. 366:409–420. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Xu Q, Ohara N, Chen W, Liu J, Sasaki H, Morikawa A, Sitruk-Ware R, Johansson ED and Maruo T: Progesterone receptor modulator CDB-2914 down-regulates vascular endothelial growth factor, adrenomedullin and their receptors and modulates progesterone receptor content in cultured human uterine leiomyoma cells. Hum Reprod. 21:2408–2416. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Ohara N, Morikawa A, Chen W, Wang J, DeManno DA, Chwalisz K and Maruo T: Comparative effects of SPRM asoprisnil (J867) on proliferation, apoptosis, and the expression of growth factors in cultured uterine leiomyoma cells and normal myometrial cells. Reprod Sci. 14 8 Suppl:S20–S27. 2007. View Article : Google Scholar | |
|
Eisinger SH, Bonfiglio T, Fiscella K, Meldrum S and Guzick DS: Twelve-month safety and efficacy of low-dose mifepristone for uterine myomas. J Minim Invasive Gynecol. 12:227–233. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Boettger-Tong H, Shipley G, Hsu CJ and Stancel GM: Cultured human uterine smooth muscle cells are retinoid responsive. Proc Soc Exp Biol Med. 215:pp. 59–65. 1997; View Article : Google Scholar : PubMed/NCBI | |
|
Norian JM, Owen CM, Taboas J, Korecki C, Tuan R, Malik M, Catherino WH and Segars JH: Characterization of tissue biomechanics and mechanical signaling in uterine leiomyoma. Matrix Biol. 31:57–65. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Rogers R, Norian J, Malik M, Christman G, Abu-Asab M, Chen F, Korecki C, Iatridis J, Catherino WH, Tuan RS, et al: Mechanical homeostasis is altered in uterine leiomyoma. Am J Obstet Gynecol. 198:474.e1–e11. 2008. View Article : Google Scholar | |
|
Xu HY, Chen ZW and Wu YM: Antitumor activity of total paeony glycoside against human chronic myelocytic leukemia K562 cell lines in vitro and in vivo. Med Oncol. 29:1137–1147. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Tao XQ, Li N, Cao L, Zhang CF, Wang TJ, Ding G, Wang ZZ and Xiao W: Effect of main components from Guizhi Fuling capsule on human leiomyoma cell proliferation and contraction of isolated mouse uterine. Chin J Exp Tradit Med Form. 2:91–96. 2016. | |
|
Lu CC, Shen CH, Chang CB, Hsieh HY, Wu JD, Tseng LH, Hwang DW, Chen SY, Wu SF, Chan MW and Hsu CD: Guizhi Fuling Wan as a novel agent for intravesical treatment for bladder cancer in mouse model. Mol Med. Jan 13–2016.(Epub ahead of print). View Article : Google Scholar | |
|
McCarty MF: Targeting multiple signaling pathways as a strategy for managing prostate cancer: Multifocal signal modulation therapy. Integr Cancer Ther. 3:349–380. 2004. View Article : Google Scholar : PubMed/NCBI |
